- Home
- Shop
- New Categories
- New Blog
- Contact Us
- Cart
- Login
- Register
Select the image to view it full size.
Product details
Catalog number #80125
Price for #80125
Size / count 1x 1 mg
CF® dye labeled dextrans could be used as a fluorescent fluid-phase markers to study cell permeability, endocytosis, or mechanisms of biomolecular delivery. The dextran conjugates are available in a variety of molecular weights, and contain a formaldehyde-fixable free-amine group. CF® dyes are Biotium's line of next-generation fluorescent dyes with advantages in brightness, photostability, and conjugate specificity compared to other fluorescent dyes. Near-infrared fluorescent CF®770 dye has excitation/emission at 770/797 nm.
The catalog number for CF®770-Dextran 250,000 MW, Anionic and Fixable is #80125.
CF®770-Dextran 250,000 MW, Anionic and Fixable is available in the following size(s): 1x 1 mg.
CF®770-Dextran 250,000 MW, Anionic and Fixable is currently made to order / not held in immediate stock. Contact us for lead time.
CF®770-Dextran 250,000 MW, Anionic and Fixable is manufactured by Biotium.
Estimated delivery time for CF®770-Dextran 250,000 MW, Anionic and Fixable is approximately 15 business day(s), depending on your location.
CF® dye labeled dextrans could be used as a fluorescent fluid-phase markers to study cell permeability, endocytosis, or mechanisms of biomolecular delivery. The dextran conjugates are available in a variety of molecular weights, and contain a formaldehyde-fixable free-amine group. CF® dyes a
Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.
A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.
Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.
